Treatment for RA should involve targeting subclinical disease and reversing immune dysregulation, expert says
Search results for: etanercept
Dermatology Case Answer C: May
C) Tumor necrosis factor (TNF)–α-induced palmoplantar pustular psoriasis
ACR Winter Rheumatology Symposium: The Search for Answers in Sjögren’s Syndrome
Research has led to greater understanding of the disease, potential for better treatment options
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Tech Talk: Contraption Reduces Pain of Rheumatic Therapy Injections
Innovative device called Buzzy applies high-frequency vibration sensation and cold to soothe sting of shots
ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists
Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment
Panel Addresses Drug Safety Issues in Rheumatology Products
Black box warnings, TNF inhibitors, and tofacitinib discussed
ACR/ARHP Annual Meeting 2012: Late-Breaking Abstracts Bring Newer Research to the Forefront
Studies addressing rheumatoid arthritis (RA) flares, a potential new drug for psoriatic arthritis, and a novel agent in the treatment of active RA are among the highlights
What Rheumatologists Should Look for in Diagnosing SAPHO Syndrome
SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, and osteitis) is an obscure condition that can vex patients and clinicians
EULAR: Identify Arthritis Early, Treat it Effectively
Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis
- « Previous Page
- 1
- …
- 23
- 24
- 25
- 26
- 27
- …
- 30
- Next Page »